Laura Tadvalkar, PhD

Managing Director, Venture

Name: RA Capital
Price range: $

Laura Tadvalkar is a Managing Director with the Venture team at RA Capital Management. Laura’s primary responsibility is to work on new company creation and early-stage investments. Laura serves as a Board Director for Be Biopharma, Expansion Therapeutics, Hemab, and Aliada Therapeutics. Prior to RA Capital, Laura was a Principal at MP Healthcare Venture Management. Prior to MP, she was a Consultant at Clarion Healthcare. Laura holds a BS in Chemistry from Yale University and a PhD in Chemical Biology from Harvard University.

Department: Healthcare
Degree: PhD
Joined: 2020
University / College: Yale University, Harvard University